4//SEC Filing
Randhawa Simrat 4
Accession 0000950170-25-013485
CIK 0001690585other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:21 PM ET
Size
5.5 KB
Accession
0000950170-25-013485
Insider Transaction Report
Form 4
Randhawa Simrat
EVP, Head of R&D
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+150,000→ 150,000 totalExercise: $22.07Exp: 2035-02-02→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Documents
Issuer
Dianthus Therapeutics, Inc. /DE/
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001992260
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:21 PM ET
- Size
- 5.5 KB